US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

160.81

+0.35000.22%

Pre-market: 162.151.34+0.83%08:42 EDT

Volume:7.47M

Turnover:1.20B

Market Cap:10.95B

PE:8.82

High:161.56

Open:160.23

Low:158.67

Close:160.46

52wk High:161.56

52wk Low:83.45

Shares:68.10M

Float Shares:68.10M

Volume Ratio:0.75

T/O Rate:10.97%

Dividend:0.58

Dividend Rate:0.36%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

HomeTrust Bank Adds Specialized Healthcare Banking Division

RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating

MT Newswires Live

This Biotech Stock is Soaring 99% After Vertex Agrees to Takeover Deal

Citi Remains a Buy on Vertex Pharmaceuticals (VRTX)

Hangzhou Diagens Biotech Calls EGM to Revise Business Scope and Articles

RxSight: Alcon Partnership and Margin Improvements Offset Near-Term Sales Shortfall; Buy Rating and $11 Price Target Reiterated

Analysts’ Top Healthcare Picks: Idexx Laboratories (IDXX), RxSight (RXST)

Jagsonpal Pharma Secures Controlling Stake in Aequitas Healthcare

Did Omega Healthcare’s Removal From the Russell 1000 Dynamic Index Just Shift OHI’s Investment Narrative?

Simply Wall St.

Humanwell Healthcare Gets China Clinical Trial Approval for Morphine Derivative

MT Newswires Live

Surgical Innovations Secures Key NHS Minimally Invasive Surgery Framework Slot

Qingdao: Forging a Hub for Marine Biopharmaceutical Excellence

Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG) and Ansell (OtherANSLF)

Aligos Therapeutics' Shares Rally Following $25M Payment from Xiamen Amoytop Biotech

Clarivate to Divest Life Sciences and Healthcare Business

Healthcare Triangle registers to sell 28M shares of common stock for holders

Healthcare Stocks Decline as Investors Rotate Away from Safety

Citizens biotech analyst holds an analyst/industry conference call

3 Healthcare Etfs to Own in a Choppy Stock Market

VERAXA Biotech (NASDAQ: VRXA) Highlights BiTAC Pipeline Progress, Advances Partnering Strategy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XBI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":160.81,"timestamp":1783368000000,"preClose":160.46,"halted":0,"volume":7470555,"hourTrading":{"tag":"盘前","latestPrice":162.15,"preClose":160.81,"latestTime":"08:42 EDT","volume":25150,"amount":4072706.7474999996,"timestamp":1783428158030,"change":1.34,"changeRate":0.008333,"amplitude":0.010747},"delay":0,"changeRate":0.0021812289667206427,"floatShares":68100000,"shares":68100000,"eps":18.23,"marketStatus":"Pre-Mkt","change":0.35,"latestTime":"07-07 08:44:42 EDT","open":160.23,"high":161.56,"low":158.67,"amount":1200447068.8164,"amplitude":0.018011,"askPrice":162.26,"askSize":200,"bidPrice":161.7,"bidSize":309,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783431000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":160.81,"sharesOutstanding":63325000,"nav":160.522543,"aum":10847310853.205,"dividendRate":0.0036,"bidAskSpread":0.000286,"preHourTrading":{"tag":"盘前","latestPrice":162.15,"preClose":160.81,"latestTime":"08:42 EDT","volume":25150,"amount":4072706.7474999996,"timestamp":1783428158030,"change":1.34,"changeRate":0.008333,"amplitude":0.010747},"postHourTrading":{"tag":"盘后","latestPrice":161.1799,"preClose":160.81,"latestTime":"19:59 EDT","volume":1011885,"amount":163022745.2891,"timestamp":1783382373861,"change":0.3699,"changeRate":0.0023,"amplitude":0.006716},"volumeRatio":0.7541032224772565,"optionData":{"bulkOrders":[{"symbol":"XBI","call":true,"expireDate":1784260800000,"strike":"174.0","timestamp":1783354167981,"price":0.59,"volume":1500,"amount":88500,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1784260800000,"strike":"174.0","timestamp":1783354167910,"price":13.24,"volume":1500,"amount":1986000,"type":"-"}]},"impliedVol":0.3415,"impliedVolPercentile":0.884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":68100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7541032224772565,"shares":68100000,"dividePrice":0.5789,"high":161.56,"amplitude":0.018011,"preClose":160.46,"low":158.67,"week52Low":83.45,"pbRate":"--","week52High":161.56,"institutionHeld":0.8511,"latestPrice":160.81,"committee":0.214145,"eps":18.23,"divideRate":0.0036,"volume":7470555,"delay":0,"ttmEps":18.23,"open":160.23,"prevYearClose":121.93,"prevWeekClose":160.46,"prevMonthClose":158.25,"prevQuarterClose":158.25,"fiveDayClose":155.38,"twentyDayClose":133.42,"sixtyDayClose":130.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649808559","title":"HomeTrust Bank Adds Specialized Healthcare Banking Division","url":"https://stock-news.laohu8.com/highlight/detail?id=2649808559","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649808559?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:30","pubTimestamp":1783427400,"startTime":"0","endTime":"0","summary":"ASHEVILLE, N.C., July  07, 2026  (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NYSE: HTB), the holding company of HomeTrust Bank (“HomeTrust” or the “Bank”), today announced the addition of its new ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/07/3323177/21341/en/HomeTrust-Bank-Adds-Specialized-Healthcare-Banking-Division.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HTB","BK4581","XLV","VHT","BK4211","LABU","LU0128526141.USD","LU0029874061.USD","XBI","NOBL","TCAF","BK4550","BK4137","BK4588","IXJ","HCSG","CGCV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649896987","title":"RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2649896987","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649896987?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:08","pubTimestamp":1783426111,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of overweight and mean price target of $55.21, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649823509","title":"This Biotech Stock is Soaring 99% After Vertex Agrees to Takeover Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2649823509","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649823509?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:33","pubTimestamp":1783423980,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals stock was surging on Tuesday after Vertex Pharmaceuticals said it had agreed to buy the biotech for $10 billion.Shares of Crinetics jumped 99% to $83.69 ahead of the opening ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","IE0002270589.USD","CRNX","SG9999001176.USD","LU1093756325.SGD","IE00B19Z3B42.SGD","LU0256863811.USD","IDNA","LU1559883803.SGD","BK4532","LU2237438978.USD","XBI","IE0002141913.USD","IBBQ","BBH","LU0058720904.USD","IE0009355771.USD","LU0432979614.USD","LU0234570918.USD","VERX","LU0320765992.SGD","LU1093756168.USD","IBB","BK4567","IE00BJT1NW94.SGD","LU0889565916.HKD","VRTX","LU2362541513.USD","BK4139","LU1674673428.USD","IE00BFTCPJ56.SGD","LU2362541273.HKD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","LU2236285917.USD","BK4007","BK4533","IE00B2B36J28.USD","LU0823416689.USD","LU1674673691.USD","LU0079474960.USD","PBE","LU2456880835.USD","LU2362540622.SGD","BK4581","LU0061475181.USD","BIB","LU0289739699.SGD","IE00B19Z9Z06.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984413","title":"Citi Remains a Buy on Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984413","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984413?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:15","pubTimestamp":1783422959,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $585.00. Meacham covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU1093756168.USD","LU2462157665.USD","VERX","IE0002141913.USD","LU2237438978.USD","PBE","LU2362541513.USD","XBI","XLV","LU1778281490.HKD","IBBQ","IE00B19Z9P08.USD","SG9999001176.SGD","BK4023","BK4581","LU0889565916.HKD","LU2362541273.HKD","IDNA","LU2324357040.USD","BK4139","LU1035775433.USD","LU1430594728.SGD","LU0417517546.SGD","LU2236285917.USD","BIB","BK4567","IE00BZ9MQY76.HKD","SG9999013999.USD","LU0079474960.USD","LU1815336091.USD","LU0109394709.USD","LU0234570918.USD","LABU","VRTX","LU0432979614.USD","BK4533","IBB","IE00B894F039.SGD","BK4532","LU0757428866.USD","LU1093756325.SGD","LU1069344957.HKD","BK4585","LU2417539215.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00B19Z9Z06.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984678","title":"Hangzhou Diagens Biotech Calls EGM to Revise Business Scope and Articles","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984678?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:08","pubTimestamp":1783422498,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. Class H ( ($HK:2526) ) has issued an announcement. Hangzhou Diagens Biotechnology Co., Ltd., a Hong Kong-l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hangzhou-diagens-biotech-calls-egm-to-revise-business-scope-and-articles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hangzhou-diagens-biotech-calls-egm-to-revise-business-scope-and-articles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649859289","title":"RxSight: Alcon Partnership and Margin Improvements Offset Near-Term Sales Shortfall; Buy Rating and $11 Price Target Reiterated","url":"https://stock-news.laohu8.com/highlight/detail?id=2649859289","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649859289?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:25","pubTimestamp":1783416323,"startTime":"0","endTime":"0","summary":"RxSight, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Saxon from Needham maintained a Buy rating on t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rxsight-alcon-partnership-and-margin-improvements-offset-near-term-sales-shortfall-buy-rating-and-11-price-target-reiterated-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rxsight-alcon-partnership-and-margin-improvements-offset-near-term-sales-shortfall-buy-rating-and-11-price-target-reiterated-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4585","LABU","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649998594","title":"Analysts’ Top Healthcare Picks: Idexx Laboratories (IDXX), RxSight (RXST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649998594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649998594?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:20","pubTimestamp":1783416038,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Idexx Laboratories (IDXX) and RxSight (RXST) with bu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-idexx-laboratories-idxx-rxsight-rxst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-idexx-laboratories-idxx-rxsight-rxst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GB00B4QBRK32.GBP","BK4588","LU0170899867.USD","LU1941712348.USD","LU1291159041.SGD","BK4539","LU0690374961.EUR","BK4504","LU0345774391.USD","LU0345774631.USD","XBI","LU2404859741.USD","BK4567","LU2404859667.USD","HCSG","LU1989771016.USD","RXST","LU0029874061.USD","BK4082","BK4585","XLV","GB00B4LPDJ14.GBP","LABU","LU1941712264.USD","BK4137","LU0128526141.USD","BK4198","LU0690374615.EUR","BK4581","PAWZ","IDXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649198363","title":"Jagsonpal Pharma Secures Controlling Stake in Aequitas Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2649198363","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649198363?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:45","pubTimestamp":1783413910,"startTime":"0","endTime":"0","summary":"Jagsonpal Pharmaceuticals Ltd. ( ($IN:JAGSNPHARM) ) has issued an announcement. Jagsonpal Pharmaceuticals Limited has advanced its expansion strate...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jagsonpal-pharma-secures-controlling-stake-in-aequitas-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jagsonpal-pharma-secures-controlling-stake-in-aequitas-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","LU0128526141.USD","XLV","LU0029874061.USD","LABU","BK4581","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649983862","title":"Did Omega Healthcare’s Removal From the Russell 1000 Dynamic Index Just Shift OHI’s Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649983862","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649983862?lang=en_us&edition=fundamental","pubTime":"2026-07-07 15:32","pubTimestamp":1783409522,"startTime":"0","endTime":"0","summary":"Omega Healthcare Investors, Inc. was removed from the Russell 1000 Dynamic Index on 27 June 2026, a change that can alter how index-tracking funds and some institutional investors allocate capital to the stock.\nThis index removal highlights how non-fundamental factors, such as benchmark rebalancing, can influence liquidity, ownership mix, and investor perception of a healthcare REIT like Omega.\nWe’ll now examine how Omega’s removal from the Russell 1000 Dynamic Index could influence its...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/324452-main-header/1585187590195","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/324452-main-header/1585187590195"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-ohi/omega-healthcare-investors/news/did-omega-healthcares-removal-from-the-russell-1000-dynamic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-ohi/omega-healthcare-investors/news/did-omega-healthcares-removal-from-the-russell-1000-dynamic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QTOC","CHAT","LABU","XBI","BK4203","SRET","DEUS","BK4225","FLQL","AIPO","OHI","ARTY","BK4585","OMFL","IWF","AGIX","BK4581","BK4588","VTHR","SGLC","XLV","SRHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649602893","title":"Humanwell Healthcare Gets China Clinical Trial Approval for Morphine Derivative","url":"https://stock-news.laohu8.com/highlight/detail?id=2649602893","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649602893?lang=en_us&edition=fundamental","pubTime":"2026-07-07 15:04","pubTimestamp":1783407855,"startTime":"0","endTime":"0","summary":"China's drug regulator approved Humanwell Healthcare  subsidiary Yichang Humanwell Pharmaceutical's clinical trial for its hydromorphone hydrochloride tablets, according to a Tuesday filing with the Shanghai bourse.The company will test the semi-synthetic derivative of morphine for post-operative moderate to severe pain in adults.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","HCSG","600079","XBI","XLV","BK0070","BK4581","BK4137","BK0185","BK0188","BK4585","LABU","LU0029874061.USD","BK0239","BK0012","BK0096","BK0028","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649011906","title":"Surgical Innovations Secures Key NHS Minimally Invasive Surgery Framework Slot","url":"https://stock-news.laohu8.com/highlight/detail?id=2649011906","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649011906?lang=en_us&edition=fundamental","pubTime":"2026-07-07 14:08","pubTimestamp":1783404480,"startTime":"0","endTime":"0","summary":"Surgical Innovations ( ($GB:SUN) ) just unveiled an update. Surgical Innovations Group’s wholly owned subsidiary Elemental Healthcare has secured a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/surgical-innovations-secures-key-nhs-minimally-invasive-surgery-framework-slot?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/surgical-innovations-secures-key-nhs-minimally-invasive-surgery-framework-slot?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4588","LABU","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143958101","title":"Qingdao: Forging a Hub for Marine Biopharmaceutical Excellence","url":"https://stock-news.laohu8.com/highlight/detail?id=1143958101","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143958101?lang=en_us&edition=fundamental","pubTime":"2026-07-07 08:04","pubTimestamp":1783382696,"startTime":"0","endTime":"0","summary":"Covering over 71% of the Earth's surface, the ocean harbors more than 80% of the planet's species, offering a biodiversity far exceeding that of land and representing a veritable treasure trove for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4585","BK4581","BK4588","399441","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649677398","title":"Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG) and Ansell (OtherANSLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649677398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649677398?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:40","pubTimestamp":1783381213,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on MiMedx Group (MDXG) and Ansell (ANSLF). MiMedx Group (MDXG) In a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mimedx-group-mdxg-and-ansell-otheranslf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mimedx-group-mdxg-and-ansell-otheranslf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4139","XBI","ANSLF","BK4588","LU0029874061.USD","BK4585","XLV","MDXG","BK4198","LABU","BK4581","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649674118","title":"Aligos Therapeutics' Shares Rally Following $25M Payment from Xiamen Amoytop Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2649674118","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649674118?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:53","pubTimestamp":1783374780,"startTime":"0","endTime":"0","summary":"Shares of Aligos Therapeutics surged after the company received a $25 million upfront payment as part of a licensing deal with Xiamen Amoytop Biotech.The stock was up 20% to $7.02 in after-hours trading Monday. Shares closed the market session up 4.7% at $5.85, but are still down 37% this year.The pact between the two companies is for pevifoscorvir sodium, a hepatitis B treatment, in Greater China.Aligos said it was eligible to receive up to $420 million in payments based on clinical, regulatory and sales milestones. The clinical stage biopharmaceutical company also said it may receive tiered, high-single-digit royalties on net sales in Amoytop's licensed territories.Aligos retains all development and commercialization rights for pevifoscorvir sodium in all other markets, including the U.S., Europe and South Korea.Chief Executive Lawrence Blatt said Amoytop would introduce Aligos' antisense oligonucleotide into the clinic in China in the third quarter.Write to Grace Yoon at grace.yoon@","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688278","BK4585","BK4139","BK4505","XBI","BK4581","ALGS","BK0239","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649367499","title":"Clarivate to Divest Life Sciences and Healthcare Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2649367499","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649367499?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:33","pubTimestamp":1783373634,"startTime":"0","endTime":"0","summary":"Clarivate ( ($CLVT) ) has provided an announcement. On July 3, 2026, Clarivate agreed to sell its Life Sciences and Healthcare business to an Altar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clarivate-to-divest-life-sciences-and-healthcare-business?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clarivate-to-divest-life-sciences-and-healthcare-business?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","LU0029874061.USD","BK4588","XBI","BK4585","XLV","LU0128526141.USD","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649745266","title":"Healthcare Triangle registers to sell 28M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2649745266","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649745266?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:25","pubTimestamp":1783373108,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 28M shares of common stock. The company is not sel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/healthcare-triangle-registers-to-sell-28m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/healthcare-triangle-registers-to-sell-28m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4588","LABU","BK4585","BK4581","BK4167","HCTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649067115","title":"Healthcare Stocks Decline as Investors Rotate Away from Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=2649067115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649067115?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:45","pubTimestamp":1783370700,"startTime":"0","endTime":"0","summary":"Stocks in the healthcare sector fell  as investors rotated away from lower-risk industries amid growing tech bullishness.Invivyd said regulators are ending emergency use authorization for its Covid-19","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BK4581","HCSG","ISBC","BK4588","XBI","LU0128526141.USD","LU0029874061.USD","LABU","XLV","BK4211","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649982676","title":"Citizens biotech analyst holds an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2649982676","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649982676?lang=en_us&edition=fundamental","pubTime":"2026-07-07 02:35","pubTimestamp":1783362912,"startTime":"0","endTime":"0","summary":"Biotech Analysts discuss understanding the developing landscape in NHL (relevant companies ALLO CLLS CRBU GILD INCY LYEL) on an Analyst/Industry co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citizens-biotech-analyst-holds-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citizens-biotech-analyst-holds-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673691.USD","XBI","LU1934455863.HKD","IE00B7SZLL34.SGD","LYEL","LU0320765992.SGD","BK4566","IE00BKVL7J92.USD","BIB","LU0965508806.USD","LU0234570918.USD","LU0965509101.SGD","BK4585","SG9999015978.USD","LU1934455277.USD","IE00B19Z3B42.SGD","LU0965509010.AUD","BK4139","LU0861579265.USD","LU1057294990.SGD","LU0114720955.EUR","LU1778281490.HKD","LU2112291526.USD","BK4532","LU1571399168.USD","LU1037948541.HKD","IBBQ","LU0965509283.SGD","LU0109394709.USD","SG9999015945.SGD","BK4581","BK4505","LU0122379950.USD","IE00B3T34201.USD","LU2468319806.SGD","BMED","IE00B19Z3581.USD","LU0289739699.SGD","LU1037948897.HKD","IBB","GILD","IE00BSNM7G36.USD","LU2089984988.USD","LU0889565916.HKD","MEDI","BK4583","LU1934455194.USD","BBH","LU1839511570.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649675418","title":"3 Healthcare Etfs to Own in a Choppy Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2649675418","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649675418?lang=en_us&edition=fundamental","pubTime":"2026-07-07 02:04","pubTimestamp":1783361040,"startTime":"0","endTime":"0","summary":"Nervous about all the volatility in semiconductor stocks and the broader tech sector?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","BK4581","BK4588","XLV","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649753526","title":"VERAXA Biotech (NASDAQ: VRXA) Highlights BiTAC Pipeline Progress, Advances Partnering Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2649753526","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649753526?lang=en_us&edition=fundamental","pubTime":"2026-07-07 01:00","pubTimestamp":1783357208,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, July 6th, 2026, FinanceWire VERAXA Biotech (NASDAQ:VRXA) provided a corporate and pipeline update highlighting p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-highlights-bitac-pipeline-progress-advances-partnering-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-highlights-bitac-pipeline-progress-advances-partnering-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTEC","BK4581",".IXIC","QQQA","TQQQ","VRXA","ONEQ","QYLG","QQQE","QLD","PSQ","QQQM","BK4097","TQQY","LU2065732104.USD","BK4588","QQQY","NDX","SQQQ","QQQJ","TECS","BK4139","QQQ","QID","MNQmain","NQmain","XBI","BK4585","NVIW.SI","PRGS","IYW","GPIQ","JEPQ","QDTE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":1,"totalSize":333,"code":"91000000","status":"200"}]}}